nDash.com is a content creation platform that provides brands and agencies with access to the world's top freelance writers.

nDash Writer Profile for Joseph Harrison

Headline

20+ Year Legal and Compliance Executive in the Pharmaceutical, Medical Device Sector

About Me

Over twenty years of experience as an FDA regulatory attorney and life sciences industry executive having expertise in pharmaceutical, biotechnology, and medical device law, regulation, and enforcement; development and implementation of corporate ethics & compliance programs; execution of government affairs/public policy plans; and in federal/state regulatory affairs, compliance, and quality systems.

Expertise in FDA law and regulation spans global marketing authorizations, clinical trials and research, advertising & promotion, current good manufacturing practices (CGMP), post-approval requirements, risk management, recalls, audits, investigations, agency inspections, and related matters, including regulatory meetings, injunctions, consent decrees, and civil or criminal investigations.

Industries I Write About

Law & Politics

Science & Medicine

My Writing Samples

Compounding Still in the Mix: Title I of the DQSA, the Compounding Quality Act, Three Years Later

In the three years since the DQSA’s Compounding Quality Act (CQA) took effect there have been significant legal and regulatory developments in drug compounding. Learn where compounders, FDA, States, Congress, and pharmaceutical companies stand on the many issues affecting this important, yet challenging, practice. Speakers will cover pressing issues such as the still-unsettled office use compounding debate, FDA’s draft guidance on “essentially copies” of approved drugs, the status of FDA’s draft

https://www.fdli.org/2017/05/compounding-still-mix-dqsa-compounding-quality-act-three-years-later/

Real World Evidence: Challenges and Opportunities

Maryland State Bar Association, Vol. 4, Issue 1 · Sep 22, 2022 Exploring how FDA is now integrating "Real World Evidence" from clinical trials into regulatory decision making

https://www.msba.org/

Experience

Managing Attorney, FDA & Life Sciences Practice

Boutique law practice exclusively focused on the FDA, EPA, FTC, DEA-regulated sectors with an emphasis on regulatory compliance and enforcement, customs/trade compliance, litigation, and U.S./Intl. business counsel.

Company: Benjamin L. England & Associates, LLC

I worked there from 3/2021 until now

Of Counsel, FDA & Life Sciences Practice

The largest health care and life sciences-focused law firm in the United States recognized as one of the nation’s preeminent health law firms for the past fifty years. Clients include large and small businesses from a wide array of life science disciplines and major health care providers.

Company: Hall, Render, Killian, Heath & Lyman, P.C.

I worked there from 10/2019 until 3/2021

Vice President - Associate General Counsel & Group Compliance Officer

One of the largest global generics purchasing organizations, leading specialty pharmaceutical services provider and the partner with more community and health system pharmacy relationships

Company: AmerisourceBergen Corporation

I worked there from 4/2016 until 10/2019

Chief Regulatory Affairs Officer, General Counsel & Corporate Secretary

Top-tier quality & regulatory consultancy of over 500 professionals serving the life science industry including medical device, biologic and pharmaceutical manufacturers worldwide.

Company: Regulatory Compliance Associates, Inc., a Nelson Laboratories Company

I worked there from 12/2013 until 4/2016

Executive Vice President, Global Quality & Compliance

Capital diagnostic & monitoring medical device, in-vitro diagnostic, software, pharmaceutical & biotechnology manufacturer

Company: GE Healthcare

I worked there from 6/2011 until 12/2013

Content I Write